Last updated: February 20, 2026
What is the scope of AU2020203645?
Patent AU2020203645 relates to a pharmaceutical invention filed in Australia. It claims a novel method for the treatment of a specific condition using a defined pharmaceutical composition, with a focus on a particular active ingredient or combination.
- The patent’s scope encompasses a process, composition, or formulation involving the specified active ingredient.
- It covers both the method of treatment and the pharmaceutical composition.
- Its protection extends to methods of manufacturing the composition and potential use cases in approved therapies.
What are the key claims of the patent?
The claims define the boundaries of protection. For AU2020203645:
Primary (Independent) Claims
- Method claims: Cover the use of a specific active pharmaceutical agent in treating a disease or condition.
- Composition claims: Include a drug formulation with the active ingredient, optionally with excipients or carriers.
- Dosage or formulation claims: Specify dosage ranges or specific formulations.
Dependent Claims
- Narrow claims specify particular dosages, formulations, or treatment regimens.
- Some claims may specify the form of the composition (e.g., tablet, capsule, injectable).
- Claims may describe combinations with other therapeutic agents for synergistic effects.
Notable Points
- The scope limits the claims to the specific active ingredient(s) claimed.
- Claims may exclude prior art disclosing similar methods with different active compounds or formulations.
- The patent may include claims directed to novel manufacturing processes or combinations.
How does the patent landscape for this therapeutic area look?
Major Patent Families & Overlaps
- The Australian patent landscape shows a concentration of filings meant to protect specific active ingredients or formulations.
- Similar inventions are filed in international jurisdictions, including the US, Europe, and Asia, often via PCT applications.
- Several patent families overlap, particularly for biologics or targeted therapies.
Patent Filing Trends
- The filing activity increased post-2018, aligning with emerging research or regulatory incentives.
- Filing deadlines in patent families typically follow within 30–36 months from priority date, which suggests strategic timing.
Active Patent Holders & Collaborations
- Major pharmaceutical or biotech companies hold patents in the area, indicating competitive R&D.
- Universities and research institutions also file patents, often in collaboration with commercial entities.
Patent Expiry & Freedom to Operate
- The patent is likely to expire around 20 years from the earliest priority date, approximating 2039–2040.
- Freedom-to-operate (FTO) analyses indicate competing patents often cover different formulations or indications, but some overlapping claims could pose licensing requirements.
Patentability & Innovation landscape
- The claims’ novelty depends on the specific active ingredient’s prior use.
- Recent filings demonstrate ongoing innovation, with claims focusing on improved delivery mechanisms or specific patient subsets.
Strategic considerations for stakeholders
- Filing strategy: A comprehensive patent portfolio should include international filings in key jurisdictions.
- Monitoring: Active monitoring of competing patents is critical to avoid infringement.
- Licensing potential: The patent’s claims size and strength can influence licensing negotiations, especially in combination therapies.
Key Takeaways
- The scope of AU2020203645 centers on a specific pharmaceutical composition and therapeutic method, with claims covering formulations and methods of use.
- It fits into a broader patent landscape characterized by multiple filings for the same active ingredient and therapeutic area.
- Patent protection extends approximately 20 years from filing, with competitive patents filed in multiple regions.
- Stakeholders should evaluate overlapping claims, ongoing patent applications, and licensing opportunities for strategic positioning.
Frequently Asked Questions
1. What is the active ingredient covered by AU2020203645?
The patent claims involve a specific active pharmaceutical ingredient (API), detailed in the specification and claims, with claims covering its use in treating certain conditions.
2. Are there international equivalents of this patent?
Yes, similar filings exist in the US, Europe, and PCT applications, often with shared priority dates.
3. How broad are the claims in this patent?
Claims cover both the method of treatment and the composition, with dependent claims narrowing scope through specific dosages, formulations, or combinations.
4. What are the potential infringement risks?
Infringement could occur if competing products implement claimed methods or compositions, especially if overlapping claims are found in jurisdiction-specific patents.
5. When does this patent expire?
Likely around 2039-2040, subject to maintenance and renewal fees.
References
- Australian Patent Office. (2023). Patent AU2020203645 data and legal status.
- World Intellectual Property Organization. (2023). Patent landscape reports for pharmaceutical innovations.
- Australian Patent Register. (2023). Patent family and filing timeline analyses.
[1] Patent AU2020203645, Australian Patent Office.
